EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hit screening with multivariate robust outlier detection

Hui Sun Leong iD, Tianhui Zhang, Adam Corrigan, Alessia Serrano, Ulrike Künzel, Niamh Mullooly, Ceri Wiggins, Yinhai Wang iD, Steven Novick

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0310433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Hui Sun Leong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Data Sciences and Quantitative Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: High-Throughput Screening Assays. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hit screening, which involves the identification of compounds or targets capable of modulating disease-relevant processes, is an important step in drug discovery. Some assays, such as image-based high-content screenings, produce complex multivariate readouts. To fully exploit the richness of such data, advanced analytical methods that go beyond the conventional univariate approaches should be employed. In this work, we tackle the problem of hit identification in multivariate assays. As with univariate assays, a hit from a multivariate assay can be defined as a candidate that yields an assay value sufficiently far away in distance from the mean or central value of inactives. Viewed another way, a hit is an outlier from the distribution of inactives. A method was developed for identifying multivariate hit in high-dimensional data sets based on principal components and robust Mahalanobis distance (the multivariate analogue to the Z- or T -statistic). The proposed method, termed mROUT (multivariate robust outlier detection), demonstrates superior performance over other techniques in the literature in terms of maintaining Type I error, false discovery rate and true discovery rate in simulation studies. The performance of mROUT is also illustrated on a CRISPR knockout data set from in-house phenotypic screening programme.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Screening AssaysMultivariate AnalysisHumansDrug DiscoveryAlgorithmsPrincipal Component AnalysisComputer Simulation

Autor:innen und Institutionen

  • Data Sciences and Quantitative Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Data Sciences and Quantitative Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, United States of America.
  • Functional Genomics, Discovery Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.

ORCID-Profile: Hui Sun Leong, Yinhai Wang

Zitieren

APA

Leong, H. S., Zhang, T., Corrigan, A., Serrano, A., Künzel, U., Mullooly, N., Wiggins, C., Wang, Y., & Novick, S. (2024). Hit screening with multivariate robust outlier detection. PLOS ONE. https://doi.org/10.1371/journal.pone.0310433

Vancouver

Leong HS, Zhang T, Corrigan A, Serrano A, Künzel U, Mullooly N, et al. Hit screening with multivariate robust outlier detection. PLOS ONE. 2024. doi:10.1371/journal.pone.0310433

BibTeX
@article{Leong2024,
  author = {Leong, Hui Sun and Zhang, Tianhui and Corrigan, Adam and Serrano, Alessia and Künzel, Ulrike and Mullooly, Niamh and Wiggins, Ceri and Wang, Yinhai and Novick, Steven},
  title = {Hit screening with multivariate robust outlier detection},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0310433}
}
Kostenlos starten →